Literature DB >> 16861360

Immune thrombocytopenic purpura does not exhibit a disparity in prevalence between African American and White veterans.

Ola Landgren, Gloria Gridley, Thomas R Fears, Neil Caporaso.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16861360     DOI： 10.1182/blood-2006-03-010405

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  5 in total

1.  Racial variation in ITP prevalence and chronic disease phenotype suggests biological differences.

Authors:  Taylor Olmsted Kim; Amanda B Grimes; Susan E Kirk; Megan M Gilbert; Helen D Reed; Kristen A Staggers; Lauryn A Walker; Abinaya Arulselvan; A Sarah Cohen; Michele P Lambert; Jenny M Despotovic
Journal:  Blood       Date:  2020-07-30       Impact factor: 22.113

Review 2.  Disease-Specific Health Disparities: A Targeted Review Focusing on Race and Ethnicity.

Authors:  Mark R Cullen; Adina R Lemeshow; Leo J Russo; David M Barnes; Yaa Ababio; Aida Habtezion
Journal:  Healthcare (Basel)       Date:  2022-03-23

3.  Primary immune thrombocytopenia (ITP) treated with romiplostim in routine clinical practice: retrospective study from the United Kingdom ITP Registry.

Authors:  Indraraj Umesh Doobaree; Adrian Newland; Vickie McDonald; Raghava Nandigam; Lesley Mensah; Sandrine Leroy; Anouchka Seesaghur; Hitan Patel; Sally Wetten; Drew Provan
Journal:  Eur J Haematol       Date:  2019-03-07       Impact factor: 2.997

4.  Comorbidities of idiopathic thrombocytopenic purpura: a population-based study.

Authors:  M A Feudjo-Tepie; G Le Roux; K J Beach; D Bennett; N J Robinson
Journal:  Adv Hematol       Date:  2009-04-02

5.  Assessment of acquired hemophilia patient demographics in the United States: the Hemostasis and Thrombosis Research Society Registry.

Authors:  Craig M Kessler; Alice D Ma; Hamid A B Al-Mondhiry; Robert Z Gut; David L Cooper
Journal:  Blood Coagul Fibrinolysis       Date:  2016-10       Impact factor: 1.276
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.